RHONDA
LIVE

Serial Number

79289155

Owner

SpinDiag GmbH

Attorney

Ursula B. Day

Filing Date

May 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RHONDA Trademark

Serial Number: 79289155 • Registration: 6513454

RHONDA is a trademark filed by SpinDiag GmbH on May 15, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SpinDiag GmbH (5 trademarks)

Engesserstr. 4

Entity Type: 99

Trademark Details

Filing Date

May 15, 2020

Registration Date

October 12, 2021

Published for Opposition

July 27, 2021

Goods & Services

Computer hardware and recorded and downloadable software for diagnostic purposes, namely, for operating and configuring blood oxygen saturation processing apparatus for diagnostic tests and displaying apparatus in the nature of computer hardware used for displaying for diagnostic results; mobile apps for diagnostic purposes, namely, downloadable mobile applications for use in data management of diagnostic results and in management of operation of diagnostic apparatus; laboratory apparatus and instruments for diagnostic purposes, namely, analyzers for sample preparation for analyzing blood and other bodily fluids, and for nucleic acid amplification and detection; laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; scientific apparatus and instruments, namely, analyzers for nucleic acid amplification and detection and fluid handling device used for disposable bioprocessing applications and parts and fittings therefor; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids

Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical use; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; reagents for medical use; chemical preparations for testing blood for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical purposes for detecting the presence of pathogenic bacteria, viruses, fungi and parasites; diagnostic preparations and materials, namely, diagnostic preparations for veterinary purposes and diagnostic preparations for medical purposes; clinical diagnostic reagents for medical purposes

Chemical products for diagnostic use, namely, laboratory chemicals in the nature of nucleic acid amplification reagents used for the detection of nucleic acids of pathogens for in vitro diagnostic use for scientific purposes, chemical preparations for scientific diagnostic purposes; chemical reagents for chemical analyses for non­ medical purposes; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; chemical reagents for use in analytical tests, other than for medical or veterinary use; chemical reagents for laboratory use, other than for medical or veterinary use; nucleic acid for use in nucleic acid amplification processes other than for medical or veterinary use; chemicals for use in performing nucleic acid polymerase chain reactions for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; nucleic acid amplification reagents other than for medical or veterinary use

Apparatus, instruments and equipment for diagnostic purposes, namely, diagnostic apparatus for the detection of pathogenic bacteria, viruses, fungi and parasites as well as their resistances; automatic analyzers for medical diagnosis, namely, nucleic acid amplification and detection apparatus; analyzers for bacterial identification for medical purposes; apparatus for analyzing bacteria in biological samples for medical use; automated analyzers for body fluids for medical use in the nature of medical diagnostic instruments for the analysis of body fluids; automated analyzers for foreign matter contained in body fluids for medical use in the nature of medical diagnostic instruments for the analysis of pathogenic bacteria, viruses, fungi and parasites as well as their resistances contained in body fluids; automated analyzers for pathogenic bacteria, viruses, fungi and parasites as well as their resistances contained in body fluids for medical use in the nature of medical diagnostic instruments for the analysis of pathogenic bacteria, viruses, fungi and parasites as well as their resistances contained in body fluids; electronic analyzers for medical purposes, namely, apparatus for nucleic acid amplification and detection for medical diagnostics; photometric and fluorescence-based analyzers of nucleic acid amplification reactions for medical use; physical analyzers of pathogenic bacteria, viruses, fungi and parasites for medical use; genetic testing apparatus for medical purposes in the nature of apparatus for nucleic acid testing for medical purposes; blood testing apparatus; apparatus for blood analysis for medical use; automated analyzers in the nature of nucleic acid analyzers for medical diagnostic uses; diagnostic apparatus for medical purposes, namely, for testing for pathogenic bacteria, viruses, fungi and parasites; analyzers for medical use, namely, medical instruments for analyzing and identifying pathogenic bacteria, viruses, fungi and parasites; medical apparatus and instruments for detecting pathogenic bacteria, viruses, fungi and parasites; diagnostic test kits comprised of enzymes, oligonucleotides and further nucleic acid amplification and detection reagents for detecting the existence of multi-resistant germs in human body fluids and of blood disorders

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 21, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 10, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 17, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 17, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 12, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 12, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 27, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Jul 24, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 7, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 7, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 24, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 24, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 24, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 24, 2021 CNEA
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Apr 19, 2021 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Apr 19, 2021 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Apr 19, 2021 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 5, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 4, 2021 GNFN
FINAL REFUSAL E-MAILED
Feb 4, 2021 GNFR
FINAL REFUSAL WRITTEN
Feb 4, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 2, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 18, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 18, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 18, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 18, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 18, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 18, 2020 COAR
REFUSAL PROCESSED BY IB
Sep 5, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 20, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 20, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 15, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jul 14, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 14, 2020 MAFR
ASSIGNED TO EXAMINER
Jul 13, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 9, 2020 REPR